
Site burden is now measured through satisfaction surveys, in-the-moment check-ins, and adoption patterns, but each method catches a different moment, and the gaps between them decide whether teams can act before burden becomes risk.
ACM Global Laboratories, an affiliate of Rochester Regional Health, announced a new therapeutic service to support the specific testing needs of oncology clinical trials, called Smarter Testing for Oncology. It brings together key elements to optimize oncology clinical trial outcomes.
Read the full release






